Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP418967.RAEXEYURROgCnywJDc2LMEJp4UQfRdDZiLQqx3F18K3cg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP418967.RAEXEYURROgCnywJDc2LMEJp4UQfRdDZiLQqx3F18K3cg130_assertion type Assertion NP418967.RAEXEYURROgCnywJDc2LMEJp4UQfRdDZiLQqx3F18K3cg130_head.
- NP418967.RAEXEYURROgCnywJDc2LMEJp4UQfRdDZiLQqx3F18K3cg130_assertion description "[Somatic, heterozygous ASXL1 mutations were identified in 14/48 (29%) of patients with GATA2 deficiency, including four out of five patients who developed a proliferative chronic myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418967.RAEXEYURROgCnywJDc2LMEJp4UQfRdDZiLQqx3F18K3cg130_provenance.
- NP418967.RAEXEYURROgCnywJDc2LMEJp4UQfRdDZiLQqx3F18K3cg130_assertion evidence source_evidence_literature NP418967.RAEXEYURROgCnywJDc2LMEJp4UQfRdDZiLQqx3F18K3cg130_provenance.
- NP418967.RAEXEYURROgCnywJDc2LMEJp4UQfRdDZiLQqx3F18K3cg130_assertion SIO_000772 24077845 NP418967.RAEXEYURROgCnywJDc2LMEJp4UQfRdDZiLQqx3F18K3cg130_provenance.
- NP418967.RAEXEYURROgCnywJDc2LMEJp4UQfRdDZiLQqx3F18K3cg130_assertion wasDerivedFrom befree-20150227 NP418967.RAEXEYURROgCnywJDc2LMEJp4UQfRdDZiLQqx3F18K3cg130_provenance.
- NP418967.RAEXEYURROgCnywJDc2LMEJp4UQfRdDZiLQqx3F18K3cg130_assertion wasGeneratedBy ECO_0000203 NP418967.RAEXEYURROgCnywJDc2LMEJp4UQfRdDZiLQqx3F18K3cg130_provenance.